AKT1 and neoplasm: Our results provide novel data which indicates that the anti-tumor activity of GEGR (including activation of apoptosis, arrest of cell cycle and suppression of cell migration) is associated with the inhibition of MAPK, NK-κB and PI3K/AKT signaling pathways during the development of lung carcinoma.